Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
about
Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesisHost microenvironment in breast cancer development: inflammatory and immune cells in tumour angiogenesis and arteriogenesisTumors: wounds that do not heal-reduxAngiogenesis in epithelian ovarian cancer.Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.Cancer-derived VEGF plays no role in malignant ascites formation in the mouse.Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural effusionsRole of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralizationStimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin.Role of endothelin-1 in neovascularization of ovarian carcinomaSignificance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer.Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesionsDiagnostic accuracy of vascular endothelial growth factor for malignant pleural effusion: A meta-analysis.Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with suspected ovarian cancerVascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue.Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis.Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levelsWhere is VEGF in the body? A meta-analysis of VEGF distribution in cancer.Concentration of vascular endothelial growth factor in the tumour tissue as a prognostic factor of soft tissue sarcomas.Positive feedback between vascular endothelial growth factor-A and autotaxin in ovarian cancer cellsThe Development of Novel Therapies for Rheumatoid ArthritisThe role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusionThe VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer.Serum vascular endothelial growth factor in pediatric patients with community-acquired pneumonia and pleural effusion.Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo.The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment.Angiopoietin-1 promotes atherosclerosis by increasing the proportion of circulating Gr1+ monocytes.Streptococcus pneumoniae induces secretion of vascular endothelial growth factor by human neutrophils.Differential expression of vascular endothelial growth factor-A, -C and -D for the diagnosis and prognosis of cancer patients with malignant effusions.Wide spectrum of antitumor activity of a neutralizing monoclonal antibody to human vascular endothelial growth factor.Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen.Stimulation by thyroid-stimulating hormone and Grave's immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo.High circulating angiopoietin-2 levels exacerbate pulmonary inflammation but not vascular leak or mortality in endotoxin-induced lung injury in mice.Expression of vascular endothelial growth factor and E-cadherin in human ovarian cancer: association with ascites fluid accumulation and peritoneal dissemination in mouse ascites model.
P2860
Q24684263-F719DD6E-C3C4-453A-BF77-130F9AE24F80Q24795592-6821ED6A-3DDB-4031-B2B9-AF500F3BB19BQ26853439-607F7DE2-E28F-411B-B81F-4C24B4ABDF22Q33919078-D70E5582-8E33-410D-9FDD-EBAF9F2B774EQ34292373-6F27D983-5DB9-42B9-99AF-45C1655392EBQ35059600-CAD750B4-D3A2-4AF0-A839-B7731A6A8664Q35533253-74FB391C-90CB-4A18-A934-C64C0BA6EA59Q35753569-E5A8CB08-AEF8-4C25-B763-7A246CC939D3Q35782323-5D57F72B-B4F9-4DAD-8AC0-DDFE9BC77A7EQ35829525-3B037908-0E75-41FF-8908-B6A8D5BEB53DQ35954103-7E73626F-BA18-4B9D-A59F-80DB7D9A851DQ36186755-113757BA-F84B-4F6B-BE7B-27DC11767D01Q36224809-B89CA161-682F-47A2-A423-EE38E58C90B8Q36292714-F33DA401-8EA6-4F4E-A9FC-3A5430793433Q36363302-401E3473-3B58-4C1D-8DB6-08812C5A25AFQ36363657-D05D8775-8DBD-400F-94E4-D5E938522D21Q36431375-7525484A-9EEC-49D5-B26C-D05771B014E6Q36611325-821747F1-9A06-46D4-80CE-7A0D737ECB5BQ36622433-9C8B7A62-0D99-48BB-9100-E8602AAF2C40Q36742070-E5F7487E-0F54-47D6-AD5C-7466AFD425FFQ36801049-955EB795-DD5B-4FB6-A0DB-F9977FBF9F34Q36907325-1076EF02-58B3-453D-BDEB-3227445387F3Q37141960-2E3558AF-F42A-46B4-B884-A8DC2FEB9D25Q37313133-F27FF163-25E0-4ED8-A56D-72540813A885Q37360588-ABDD182F-7947-43E8-8B35-5540AC7FB7D3Q37516448-1CE6401E-4F74-4057-BC40-FF82F5A08949Q37572203-444B48EE-586F-4DFD-A664-BBC9CE69D29BQ39520836-12E1324C-1683-4CCA-8E4D-53C43799A18FQ40257822-06C6B5DF-3021-4A86-8928-FB1E95FCCAE0Q40967208-10CC9030-99EB-41CD-AF6F-702790436B89Q41940732-5D0F8E56-2ED4-4F95-9973-60650BC1B7E7Q42127588-A6B658BC-D064-4D08-9B42-81CAF57219C6Q47744102-51D8F0E9-623B-437E-BEF0-407D776DCB71Q55094535-20BDCB61-16D2-4FCA-8834-FECA1FAE0CB9
P2860
Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Vascular permeability factor ( ...... or and inflammatory effusions.
@en
Vascular permeability factor
@nl
type
label
Vascular permeability factor ( ...... or and inflammatory effusions.
@en
Vascular permeability factor
@nl
prefLabel
Vascular permeability factor ( ...... or and inflammatory effusions.
@en
Vascular permeability factor
@nl
P2093
P1433
P1476
Vascular permeability factor ( ...... mor and inflammatory effusions
@en
P2093
Hoogewerf AJ
Ledbetter SR
Sioussat TM
P304
P407
P577
1993-06-01T00:00:00Z